Subject(s)
Asthma/drug therapy , Bronchitis/drug therapy , Indomethacin/administration & dosage , Levamisole/administration & dosage , Lymphopenia/drug therapy , Adult , Asthma/immunology , Bronchitis/immunology , Chronic Disease , Drug Therapy, Combination , Female , Humans , Male , Middle Aged , T-LymphocytesSubject(s)
Bronchitis/physiopathology , Heart Failure/diagnosis , Hemodynamics , Chronic Disease , Humans , Prognosis , Time FactorsABSTRACT
Based on a study of the clinical efficacy of endolymphatic administration of antibiotics in 160 patients with different pulmonary diseases the methods of the use of endolymphatic therapy (ET) as part of a complex of therapeutic measures for lung abscess, pneumonia, chronic purulent bronchitis have been devised. The pharmacodynamics of gentamicin, brulamicin, pentrexyl, ketocef and claforan administered endolymphatically has been explored. Positive shifts have been demonstrated in cyclic nucleotides and immune responsiveness during ET, a constituent part of multiple modality treatment.
Subject(s)
Anti-Bacterial Agents/administration & dosage , Respiratory Tract Diseases/drug therapy , Adolescent , Adult , Aged , Ampicillin/administration & dosage , Ampicillin/blood , Anti-Bacterial Agents/blood , Bronchitis/drug therapy , Cefotaxime/administration & dosage , Cefotaxime/blood , Cefuroxime/administration & dosage , Cefuroxime/blood , Evaluation Studies as Topic , Female , Humans , Injections, Intralymphatic/methods , Lung Abscess/drug therapy , Male , Middle Aged , Pneumonia/drug therapy , Respiratory Tract Diseases/blood , Respiratory Tract Diseases/immunology , Tobramycin/administration & dosage , Tobramycin/bloodSubject(s)
Lung Diseases/diagnosis , Thermography/methods , Adolescent , Adult , Aged , Cholesterol , Crystallization , Female , Humans , Male , Middle Aged , Time FactorsSubject(s)
Amyloidosis/etiology , Tuberculosis, Pulmonary/complications , Amyloid/metabolism , Amyloidosis/diagnosis , Amyloidosis/pathology , Bronchi/metabolism , Bronchi/pathology , Chronic Disease , Humans , Lung/metabolism , Lung/pathology , Pneumonia/complications , Pneumonia/metabolism , Pneumonia/pathology , Tuberculosis, Pulmonary/metabolism , Tuberculosis, Pulmonary/pathologySubject(s)
Tuberculosis, Pulmonary/epidemiology , Adolescent , Adult , Age Factors , Child , Humans , Mass Chest X-Ray , Middle Aged , Tuberculosis, Pulmonary/mortality , UkraineSubject(s)
Bronchitis/immunology , Tuberculosis, Pulmonary/immunology , Adult , Autoimmune Diseases/diagnosis , Autoimmune Diseases/immunology , B-Lymphocytes/immunology , Bronchitis/diagnosis , Chronic Disease , Diagnosis, Differential , Female , Humans , Immunoglobulins/analysis , Male , Middle Aged , T-Lymphocytes/immunology , Tuberculin Test , Tuberculosis, Pulmonary/diagnosisABSTRACT
The authors review some aspects of the use of medical cybernetics methods in pulmonology. Analyze the results of machine and machine-free (mark) diagnosis of chronic lung diseases. Demonstrate that the quality of the disease recognition by means of the cybernetic methods correlates with that attained by highly specialized therapeutic institutions. Discuss the results of predicting the outcomes of the treatment of respiratory system diseases and the possibilities of using the mathematical methods for the classification optimization.
Subject(s)
Cybernetics , Diagnosis, Computer-Assisted , Lung Diseases/diagnosis , Diagnosis, Differential , Humans , Lung Diseases/therapy , PrognosisABSTRACT
Follow up of 93 patients with chronic obstructive bronchitis and bronchial asthma enabled the authors to trace the effect of magnetophorotherapy combined with pathogenetic treatment on the disease progress, external respiration function, cardiovascular system, and immune responsiveness. It was shown that magnetophorotherapy is an effective therapy for bronchial obstruction, favouring the recovery and improvement of respiratory function, characteristics of the flow-volume curve. It also exerts a beneficial effect on different components of immunity.
